1-3 of 3
Christian Klinkenstein, MD
Close
Sort by
Journal Articles

Results of a Prospective Randomised Open Label Phase III Study Comparing Rituximab Plus Mitoxantrone, Chlorambucile, Prednisolone Chemotherapy (R-MCP) Versus MCP Alone in Untreated Advanced Indolent Non-Hodgkin’s Lymphoma (NHL) and Mantle-Cell-Lymphoma (MCL).

Michael Herold, MD, Rita Pasold, MD, Stefanie Srock, MD, Sabine Neser, MD, Dietger Niederwieser, MD, Andreas Neubauer, MD, Gottfried Dölken, MD, Ralph Naumann, MD, Thomas Fietz, MD, Mathias Freund, MD, Robert Rohrberg, MD, Klaus Hoeffken, MD, Astrid Franke, MD, Thomas H. Ittel, MD, Erika Kettner, MD, Ursula Haak, MD, Ullrich Mey, MD, Christian Klinkenstein, MD, Michael Assmann, MD, Ullrich von Gruenhagen, MD, Klaus Dachselt, MD, Helga Schwenke, MD, Dorothee Bleyl, MD, Heiner Wolf, MD, Sabine Hahnfeld, MD, Franz-Adolph Hoffmann, MD, Volker Lakner, MD, Peter Richter, MD, Detlev Hähling, MD, H. H. Wolf, MD, Henning Eschenburg, MD, M.-R. Clemens, MD, Norbert Grobe, MD
Journal: Blood
Blood (2004) 104 (11): 584.
https://doi.org/10.1182/blood.V104.11.584.584
Published: 2004
Journal Articles

High Complete Remission Rate in Patients with Acute Myeloid Leukemia (AML) above the Age of 60 Years: A Report of the AML97#38 Study of the East German Hematology and Oncology Study Group.

Cornelia Becker, MD, Haifa Al Ali, MD, Rainer Krahl, PhD, Wolfram Poenisch, MD, Ulrich Wedding, MD, Ferdinand Fiedler, MD, Rita Pasold, MD, Matthias Freund, MD, Rita Subert, MD, Dietrich Kaempfe, MD, Johannes Meran, MD, Manfred Herold, MD, Norma Peter, MD, Wolfgang Knauf, MD, Erika Kettner, MD, Wolfgang Schultze, MD, Klaus Dachselt, MD, Hans Heinrich Wolf, MD, Ute Kreibich, MD, Manfred Schulze, MD, Thomas Ittel, MD, Michael Assmann, MD, Norbert Grobe, MD, Renate Huhn, MD, Juergen Steglich, MD, Veronika Schirmer, MD, Christian Klinkenstein, MD, Bernhard Opitz, MD, Cornelia Winkelmann, MD, Ursula Haak, MD, Werner Helbig, MD, Dietger Niederwieser, MD
Journal: Blood
Blood (2004) 104 (11): 880.
https://doi.org/10.1182/blood.V104.11.880.880
Published: 2004
Journal Articles

Cost Evaluation of Rituximab Plus MCP vs. MCP Alone in Advanced Stage Indolent Non-Hodgkin’s-Lymphoma Based on a Randomized Controlled Multicenter Trial.

Klaus Hieke, Rita Pasold, MD, Sabine Neser, MD, Dietger Niederwieser, MD, Andreas Neubauer, MD, Gottfried Doelken, MD, Ralph Naumann, MD, Thomas Fietz, MD, Mathias Freund, MD, Robert Rohrberg, MD, Klaus Hoeffken, MD, Astrid Franke, MD, Thomas-Hein Ittel, MD, Erika Kettner, MD, Ursula Haak, MD, Ullrich Mey, MD, Christian Klinkenstein, MD, M. Assmann, MD, Ullrich von Gruenhagen, MD, Klaus Dachselt, MD, Helga Schwenke, MD, Dorothee Bleyl, MD, Heiner Wolf, MD, Sabine Hahnfels, MD, Franz-Adolph Hoffmann, MD, Volker Lakner, MD, Peter Richter, MD, Detlev Haehling, MD, H.H. Wolf, MD, H. Eschenburg, MD, N. Grobe, MD, M.-R. Clemens, MD, Michael Herold, MD
Journal: Blood
Blood (2004) 104 (11): 87.
https://doi.org/10.1182/blood.V104.11.87.87
Published: 2004